APP and Alzheimer disease: Whereas less than 1% of AD cases are attributable to genetic mutations in the genes coding for amyloid precursor protein (APP), presenilin-1 (PS1), or presenilin-2 (PS2) that contribute to the early onset form of the disease, the vast majority of AD cases are sporadic, and have a later disease onset.